This is big news, IV Relenza could be approved based on need rather than clinical trials?
Great to see the US pick up the pace with regards to anti-virals.
BCRX up 25% last night on the nasdaq... wish BTA was listed there too. Even the pink sheets were up 5%.
- Forums
- ASX - By Stock
- BTA
- white house to fast track iv anti virals